Genuit Group plc (GEN.L)
GBp 391.5
(1.16%)
GBp 391.5
(1.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 84.2 Million | 86.9 Million | 74.9 Million | 53.3 Million | 77 Million | 78.8 Million |
| Net Income | 38.5 Million | 45.4 Million | 62.9 Million | 23.8 Million | 60.1 Million | 58.5 Million |
| Depreciation & Amortization | 40.3 Million | 40.2 Million | 37.1 Million | 27.6 Million | 27.3 Million | 21.5 Million |
| Deferred income taxes | -78.59 Million | - | -14 Million | -9.6 Million | -14.4 Million | -13.3 Million |
| Stock-based compensation | 2.1 Million | 2.9 Million | 2.2 Million | 1.4 Million | 1.2 Million | 1 Million |
| Change in working capital | 4.09 Million | -19.7 Million | -27 Million | 1.5 Million | -5.9 Million | 3.8 Million |
| Other non-cash items | 77.8 Million | 18.1 Million | 13.7 Million | 8.6 Million | 8.7 Million | 7.3 Million |
| Investing Cash Flow | -28.5 Million | -44 Million | -270.5 Million | -26.3 Million | -33.6 Million | -65.7 Million |
| Investments in PPE | -34.5 Million | -43.8 Million | -34.6 Million | -25.1 Million | -22.3 Million | -24.1 Million |
| Acquisitions | 6 Million | -3.1 Million | -236.4 Million | -1.8 Million | -12.2 Million | -42.5 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 5.89 Million | 2.9 Million | 500 Thousand | 600 Thousand | 900 Thousand | 900 Thousand |
| Financing Cash Flow | -88.7 Million | -45.2 Million | 203.9 Million | -30.6 Million | -41.8 Million | -2.7 Million |
| Debt repayment | -50.9 Million | -268.3 Million | -10 Million | -238.7 Million | -13 Million | -199.1 Million |
| Dividends payments | -30.5 Million | -30.5 Million | -21.7 Million | - | -23.7 Million | -22.3 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 300 Thousand | 400 Thousand | 98.4 Million | 122.1 Million | 2.4 Million | 300 Thousand |
| Other Financing Activities | -7.6 Million | 253.2 Million | 137.2 Million | 86 Million | -7.5 Million | 218.4 Million |
| Accounts receivables | -6.9 Million | 7.8 Million | -900 Thousand | -21.3 Million | 2.2 Million | -2.9 Million |
| Accounts payables | -9.9 Million | -10.4 Million | -6.2 Million | 15.6 Million | -7.3 Million | 10.8 Million |
| Inventory | 20.9 Million | -17.1 Million | -19.9 Million | 7.2 Million | -800 Thousand | -4.1 Million |
| Other working capital | -1.00 | - | - | - | - | - |
| Cash at beginning of period | 50 Million | 52.3 Million | 44.1 Million | 47.7 Million | 46.2 Million | 35.7 Million |
| Cash at end of period | 17 Million | 50 Million | 52.3 Million | 44.1 Million | 47.7 Million | 46.2 Million |
| Capital Expenditure | -34.5 Million | -43.8 Million | -34.6 Million | -25.1 Million | -22.3 Million | -24.1 Million |
| Effect of forex changes on cash | - | - | -100 Thousand | - | -100 Thousand | 100 Thousand |
| Net cash flow / Change in cash | -33 Million | -2.3 Million | 8.2 Million | -3.6 Million | 1.5 Million | 10.5 Million |
| Free Cash Flow | 49.7 Million | 43.1 Million | 40.3 Million | 28.2 Million | 54.7 Million | 54.7 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 8.4 Million | 15.2 Million | 38.5 Million | 23.3 Million | 45.4 Million | 11.5 Million |
| Depreciation & Amortization | 19.4 Million | 21.4 Million | 40.3 Million | 20.1 Million | 40.2 Million | 20.6 Million |
| Deferred income taxes | - | -13.7 Million | -78.59 Million | -64.9 Million | - | -24.8 Million |
| Stock-based compensation | 1.6 Million | 500 Thousand | 2.1 Million | 1.6 Million | 2.9 Million | 1.3 Million |
| Change in working capital | -6.5 Million | 27.2 Million | 4.09 Million | -23.1 Million | -19.7 Million | 17.7 Million |
| Other non-cash items | 20.4 Million | 16.5 Million | 77.8 Million | 62.5 Million | 18.1 Million | 45.9 Million |
| Investing Cash Flow | -9 Million | -21.2 Million | -28.5 Million | -7.3 Million | -44 Million | -32.1 Million |
| Investments in PPE | -11.5 Million | -21.7 Million | -34.5 Million | -12.8 Million | -43.8 Million | -33.5 Million |
| Acquisitions | -1.6 Million | 500 Thousand | 6 Million | 5.5 Million | -3.1 Million | 1.4 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 4.1 Million | 100 Thousand | 5.89 Million | 5.8 Million | 2.9 Million | -1.8 Million |
| Financing Cash Flow | -25.5 Million | -54.4 Million | -88.7 Million | -34.3 Million | -45.2 Million | -39.7 Million |
| Debt repayment | -100 Thousand | -39.8 Million | -50.9 Million | -11.1 Million | -268.3 Million | -25.2 Million |
| Dividends payments | -20.6 Million | -10.1 Million | -30.5 Million | -20.4 Million | -30.5 Million | -10.2 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 800 Thousand | 300 Thousand | 300 Thousand | - | 400 Thousand | - |
| Other Financing Activities | -5 Million | -50.7 Million | -7.6 Million | -7.1 Million | 253.2 Million | -1.4 Million |
| Accounts receivables | -9.7 Million | 28.1 Million | -6.9 Million | -35 Million | 7.8 Million | 25 Million |
| Accounts payables | 6.2 Million | -13 Million | -9.9 Million | 3.1 Million | -10.4 Million | -6.5 Million |
| Inventory | 3.2 Million | 12.1 Million | 20.9 Million | 8.8 Million | -17.1 Million | -800 Thousand |
| Other working capital | - | - | -1.00 | - | - | - |
| Cash at beginning of period | 17 Million | 27.9 Million | 50 Million | 50 Million | 52.3 Million | 49.7 Million |
| Cash at end of period | 25.8 Million | 17 Million | 17 Million | 27.9 Million | 50 Million | 50 Million |
| Capital Expenditure | -11.5 Million | -21.7 Million | -34.5 Million | -12.8 Million | -43.8 Million | -33.5 Million |
| Effect of forex changes on cash | - | -17 Million | - | 50 Million | - | -100 Thousand |
| Net cash flow / Change in cash | 8.8 Million | -10.9 Million | -33 Million | -22.1 Million | -2.3 Million | 300 Thousand |
| Free Cash Flow | 31.8 Million | 43 Million | 49.7 Million | 6.7 Million | 43.1 Million | 38.7 Million |
7965
0HOH
BIOEX
7370
050890
5821